Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > REGULATORY
REGULATORY
- PMDA Announces "International Vision and Roadmap"
May 7, 2013
- MEXT to Award Up to 100 Million Yen Each to 15 National University Hospitals that Lead in Generic Drug Use
May 2, 2013
- Application of New Price Reduction Rule for Long-listed Drugs Should Distinguish between Products Which Received or Did Not Receive Premium: Mr Kamoya of FPMAJ
May 1, 2013
- First Committee Recommends Approval for New Gout, Hyperuricemia Treatment, Antihypertensive Tape Formulation
May 1, 2013
- PMRJ Introduces “RS Expert Certification System”
April 30, 2013
- PAFSC’s Second Committee Recommends Approval for Chugai’s Breast Cancer Drug Perjeta, Others
April 26, 2013
- Japan-Version NIH: Cabinet HQ to Lay Out Comprehensive Strategy, Integrate R&D Budgets
April 25, 2013
- Bill to Amend PAL Will Be Submitted to Diet in May, as Instructed by PM Abe: Mr Akagawa of PFSB
April 25, 2013
- MHLW Picks Additional Clinical Research Core Hospitals
April 23, 2013
- MHLW May Refuse Applications for Generic Drug Listing from Companies that Fail to Maintain Stable Supplies
April 23, 2013
- Experts on Council for Science and Technology Policy Back Measures to Promote Development of Innovative New Drugs Aiming at Healthy, Long-lived Society
April 19, 2013
- Reorganization of Council for Science and Technology Policy Proposed by Industrial Competitiveness Council to Create Stronger Centralized Authority
April 19, 2013
- First Committee to Discuss Approval of New Gout Treatment Topiroxostat
April 18, 2013
- Committee Finds No Problem with Quality of 8 Generic Versions of Pfizer Japan’s Unasyn-S Kit
April 18, 2013
- “Japanese Version of CTEP” Proposed at 1st Meeting of Expert Council on Future Cancer Research
April 16, 2013
- Growing Concern Over Return to Brand Names for Generics with Advent of Generic Versions of Combination Drugs
April 16, 2013
- PAFSC’s Second Committee to Review Chugai’s Breast Cancer Drug Pertuzumab on April 25
April 15, 2013
- Supreme Court Rejects Damage Claims in Iressa Suits; Govt, AZ Win 8-Year Battle
April 15, 2013
- Generic Roadmap: CSIMC Bill Payer Rep Says New 60% Target Could “Decelerate” Shift
April 12, 2013
- Cost-Effective Assessment Should Be Reflected in Pricing, Not Used as Criterion for Approval: Healthcare Reps at CSIMC
April 12, 2013
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…